Latest: FDA Approves New Biosimilar for Oncology Treatment

NICE changes mind on GP prescribing of heart failure drugs in final guidance

0 Mins
NICE has removed a requirement in its updated guidance on chronic heart failure for GPs to seek specialist advice before prescribing a sodium-glucose cotransporter-2 (SGLT2) inhibitor. It comes after several stakeholders noted that GPs have long-held experience with the class of drugs and seeking extra advice would delay care. An overhaul of the guidance published The post NICE changes mind on GP prescribing of heart failure drugs in final guidance appeared first on Pulse Today.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago